Search results
Hunter Biden's own words will convict him: legal expert
Newsweek· 1 day agoHunter Biden's own words will likely convict him on gun charges, a senior trial lawyer has told...
Hunter Biden’s Stripper Ex Dishes on Drug Abuse at Gun Trial
The Daily Beast via Yahoo News· 2 days agoTwo of Hunter Biden’s former romantic partners took the stand in his federal gun trial on Wednesday,...
Researchers Highlight Progress in Head and Neck Cancer MRD at ASCO, but Results Remain Preliminary
GenomeWeb News· 17 hours agoHNC is revealing itself to be a newly favored target for the application of minimal residual disease testing, due to the technology's potential to improve outcomes in a cancer type where initial ...
Summer House Season 8: Lindsay Hubbard and Carl Radke’s Worst Moments
Reality Tea via Yahoo News· 11 hours agoCarl’s accusations In the season finale, Carl broke up with Lindsay…on camera. During the breakup,...
Intralesional Therapy for Melanoma Effective, May Have Systemic Activity
MedPage Today· 5 days agoPreoperative antibody fusion daromun significantly reduced relapse versus upfront surgery
TECVAYLI® (teclistamab-cqyv) shows sustained deep and durable responses in patients with relapsed or...
Forrest City Times-Herald· 4 days ago"With the longest follow-up of any bispecific antibody, teclistamab demonstrates continued deep and durable responses observed in patients with relapsed or refractory multiple ...
Sunvozertinib's Global Pivotal WU-KONG1B Study Meets Primary Endpoint in Non-Small Cell Lung Cancer...
The Woonsocket Call· 5 days agoThe global pivotal WU-KONG1B study investigating sunvozertinib achieved its primary objective with a manageable safety profile in relapsed or refractory NSCLC with EGFR exon20ins ...
‘This is their family’: Close-knit Bidens turn out for Hunter’s trial
NBC Universal via AOL· 11 hours agoWILMINGTON, Del. — On Oct. 12, 2018, former Vice President Joe Biden crowded into an SUV with a...
Novel CAR T therapy and shorter targeted therapy durations show promise for patients with leukemia
Medical Xpress· 7 days agoThe novel anti-CD19 autologous chimeric antigen receptor (CAR) T cell therapy obecabtagene...
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena via Yahoo Finance· 1 day agoAbbVie has treated the first subject in the Phase III CERVINO clinical trial of its investigational...